Speaker Profile
PMWC LUMINARY AWARD
Led pivotal CAR-T trials that established cellular therapy for aggressive lymphoma
M.D., Frederick L. Locke, MD Department Chair and Senior Member, Blood and Marrow Transplant and Cellular Immunotherapy Program Leader, Cellular Immunotherapy, Moffitt Medical Group Program Leader, Immuno-Oncology Program, Moffitt Research Institute, Moffitt Cancer Ctr.
Biography
Frederick L. Locke, MD, is a physician-scientist whose work has helped shape the development and safe delivery of CAR T-cell therapy worldwide. As a leader of the pivotal clinical trials that established CAR T-cell therapy as a standard treatment for lymphoma, including ZUMA-1 and ZUMA-7, he has helped define the field's understanding and management of its potentially life-threatening toxicities. Through collaborations spanning academia, industry, professional societies, and treatment centers, Dr. Locke has helped develop the evidence, standards, and best practices that have enabled cellular therapies to safely reach patients around the world.
Talk
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
